Skip to content
Novasenta
About
our science
Careers
Contact
News
News
Press Releases
Events
Presentations
News Category:
Media Coverage
2023 Inno Fire Awards, Top Funding Rounds: Novasenta
Pharmtech Focus: Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Fierce Biotech Fundraising Tracker
Pittsburgh Inno: Novasenta raises $40M in Series A financing
Labiotech.eu: Biotech startup Novasenta raises $40M to advance novel cancer therapeutics
Endpoints Exclusive: UPMC launches another biotech, rooted in the tumor microenvironment
Next Pittsburgh: UPMC Enterprises invests $20 million in startup changing the way we fight cancer
Pittsburgh Business Times: UPMC launches cancer drug development firm Novasenta
Science Advisory Board: UPMC Launches Immunotherapy Company, Novasenta
MedCity News: UPMC launches cancer drug discovery company
Posts navigation
Older posts